MN

Mark Nelson

Telix Pharmaceuticals Limited | Non-Executive Director
Dr Nelson has experience in the investment community, including in life sciences. Dr Nelson has served as Chairman of the Caledonia Investments Group (since January 2012) and as a Director of The Caledonia Foundation (since August 2002). He previously served as Chief Executive Officer and Co-Chief Investment Officer of the Caledonia Investments Group (from February 1992 to January 2012). Dr Nelson has served as Chairman of Art Exhibitions Australia (since 2019), Director of the Mindgardens Neuroscience Network (since February 2018), Governor of the Florey Neurosciences Institute (since October 2007), and Director of Kaldor Public Art Projects (since October 2005). He is member of People, Culture and Risk Committee.

Company and Role

Company
Title
Tenure
Since
TLX
Telix Pharmaceuticals Limited
  • Non-Executive Director
7yrs, 4mthSep 2017

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
TLX
Telix Pharmaceuticals Limited
22/02/24N/A3,628,750N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
TLX
Telix Pharmaceuticals Limited
29/09/21
Exercise
990,000$0.850$841,500Exercise of options
TLX
Telix Pharmaceuticals Limited
29/09/21
Buy
990,000$0.850$841,500Exercise of options
TLX
Telix Pharmaceuticals Limited
27/02/20
Buy
400,000$1.450$580,000On-market trade